Lenalidomide FDA Link

A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.

Also Known As:

CC 5013; Revlimid; 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-; 3- (4- Amino- 1- oxoisoindolin- 2- yl)piperidine- 2,6- dione; CC-5013; CC5013; IMiD3 Cpd; Revimid

Organic Chemicals: 140
- Carboxylic Acids: 986
  - Carbocyclic Acids
    - Phthalic Acids: 1
      - Phthalimides: 14
        Lenalidomide: 3408
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - Piperidones: 39
      - Lenalidomide: 3408
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoindoles: 20
      - Phthalimides: 14
        Lenalidomide: 3408

WanXin Chen Selected Research

WanXin Chen Research Topics

Disease

Drug/Important Bio-Agent (IBA)